UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

De novo donor‐specific antibodies in belatacept‐treated vs cyclosporine‐treated kidney‐transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT‐EXT studies

American journal of transplantation, 2018-07, Vol.18 (7), p.1783-1789

2018

Volltextzugriff (PDF)

Solid Organ Allograft Survival Improvement in the United States: The Long‐Term Does Not Mirror the Dramatic Short‐Term Success

American journal of transplantation, 2011-06, Vol.11 (6), p.1226-1235

2011

Volltextzugriff (PDF)

Blood Transfusions in Organ Transplant Patients: Mechanisms of Sensitization and Implications for Prevention

American journal of transplantation, 2011-09, Vol.11 (9), p.1785-1791

2011

Volltextzugriff (PDF)

Posttransplant reduction in preexisting donor‐specific antibody levels after belatacept‐ versus cyclosporine‐based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT‐EXT

American journal of transplantation, 2018-07, Vol.18 (7), p.1774-1782

2018

Volltextzugriff (PDF)

Immunosuppression: Evolution in Practice and Trends, 1994–2004

American journal of transplantation, 2006-05, Vol.6 (5p2), p.1111-1131

2006

Volltextzugriff (PDF)

Fixed‐ or Controlled‐Dose Mycophenolate Mofetil with Standard‐ or Reduced‐Dose Calcineurin Inhibitors: The Opticept Trial

American journal of transplantation, 2009-07, Vol.9 (7), p.1607-1619

2009

Volltextzugriff (PDF)

Ten‐year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4‐weekly or 8‐weekly

American journal of transplantation, 2017-12, Vol.17 (12), p.3219-3227

2017

Volltextzugriff (PDF)

Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients

American journal of transplantation, 2008-07, Vol.8 (7), p.1384-1392

2008

Volltextzugriff (PDF)

The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation

American journal of transplantation, 2011-12, Vol.11 (12), p.2675-2684

2011

Volltextzugriff (PDF)

Long‐Term Renal Allograft Survival in the United States: A Critical Reappraisal

American journal of transplantation, 2011-03, Vol.11 (3), p.450-462

2011

Volltextzugriff (PDF)

Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

American journal of transplantation, 2011-03, Vol.11 (3), p.450-462

2011

Volltextzugriff (PDF)

Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT‐EXT at 7 Years After Transplant

American journal of transplantation, 2017-01, Vol.17 (1), p.180-190

2017

Volltextzugriff (PDF)

Mycophenolate Mofetil/Sirolimus Compared to Other Common Immunosuppressive Regimens in Kidney Transplantation

American journal of transplantation, 2007-03, Vol.7 (3), p.586-594

2007

Volltextzugriff (PDF)

Long‐Term Outcomes in Belatacept‐ Versus Cyclosporine‐Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT‐EXT, a Phase III Randomized Study

American journal of transplantation, 2016-11, Vol.16 (11), p.3192-3201

2016

Volltextzugriff (PDF)

Pulsatile Pump Decreases Risk of Delayed Graft Function in Kidneys Donated After Cardiac Death

American journal of transplantation, 2012-10, Vol.12 (10), p.2774-2780

2012

Volltextzugriff (PDF)

The Success of Continued Steroid Avoidance After Kidney Transplantation in the US

American journal of transplantation, 2009-12, Vol.9 (12), p.2768-2776

2009

Volltextzugriff (PDF)

Increased impact of acute rejection on chronic allograft failure in recent era

Transplantation, 2000-10, Vol.70 (7), p.1098-1100

2000

Volltextzugriff (PDF)

The Search for CNI‐Free Immunosuppression: No Free Lunch

American journal of transplantation, 2011-07, Vol.11 (7), p.1355-1356

2011

Volltextzugriff (PDF)

The Overlapping Risk Profile Between Dialysis Patients Listed and Not Listed for Renal Transplantation

American journal of transplantation, 2008-01, Vol.8 (1), p.58-68

2008

Volltextzugriff (PDF)

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection

Transplantation, 2000-06, Vol.69 (11), p.2405-2409

2000

Volltextzugriff (PDF)

Value of Posttransplant Antibody Tests in the Evaluation of Patients with Renal Graft Dysfunction

American journal of transplantation, 2007-07, Vol.7 (7), p.1808-1814

2007

Volltextzugriff (PDF)

Improving Long‐Term Outcomes for Transplant Patients: Making the Case for Long‐Term Disease‐Specific and Multidisciplinary Research

American journal of transplantation, 2011-10, Vol.11 (10), p.2264-2265

2011

Volltextzugriff (PDF)

Elevated Incidence of Posttransplant Erythrocytosis After Simultaneous Pancreas Kidney Transplantation

American journal of transplantation, 2010-04, Vol.10 (4), p.938-942

2010

Volltextzugriff (PDF)

A ‘Weight‐Listing’ Paradox for Candidates of Renal Transplantation?

American journal of transplantation, 2007-03, Vol.7 (3), p.550-559

2007

Volltextzugriff (PDF)

The Noninferiority Trial: Don't Don't Do It

American journal of transplantation, 2010-12, Vol.10 (12), p.2571-2573

2010

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(109)

Publikationsform

Artikel
(162)

Sprache

Englisch
(162)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Humans
(132)
Life Sciences & Biomedicine
(132)
Science & Technology
(132)
Transplantation
(103)
Surgery
(94)
Biological And Medical Sciences
(87)
Medical Sciences
(87)
Female
(78)
Male
(75)
Adult
(73)
Middle Aged
(66)
Kidney Transplantation
(63)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(58)
Immunology
(47)
Surgery Of The Urinary System
(45)
Immunosuppressive Agents - Therapeutic Use
(38)
Graft Survival
(35)
Kidney Transplantation - Immunology
(32)
Proportional Hazards Models
(32)
Risk Factors
(30)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

De novo donor‐specific antibodies in belatacept‐treated vs cyclosporine‐treated kidney‐transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT‐EXT studies

Solid Organ Allograft Survival Improvement in the United States: The Long‐Term Does Not Mirror the Dramatic Short‐Term Success

Blood Transfusions in Organ Transplant Patients: Mechanisms of Sensitization and Implications for Prevention

Posttransplant reduction in preexisting donor‐specific antibody levels after belatacept‐ versus cyclosporine‐based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT‐EXT

Immunosuppression: Evolution in Practice and Trends, 1994–2004

Fixed‐ or Controlled‐Dose Mycophenolate Mofetil with Standard‐ or Reduced‐Dose Calcineurin Inhibitors: The Opticept Trial

Ten‐year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4‐weekly or 8‐weekly

Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients

The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation

Long‐Term Renal Allograft Survival in the United States: A Critical Reappraisal

Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT‐EXT at 7 Years After Transplant

Mycophenolate Mofetil/Sirolimus Compared to Other Common Immunosuppressive Regimens in Kidney Transplantation

Long‐Term Outcomes in Belatacept‐ Versus Cyclosporine‐Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT‐EXT, a Phase III Randomized Study

Pulsatile Pump Decreases Risk of Delayed Graft Function in Kidneys Donated After Cardiac Death

The Success of Continued Steroid Avoidance After Kidney Transplantation in the US

Increased impact of acute rejection on chronic allograft failure in recent era

The Search for CNI‐Free Immunosuppression: No Free Lunch

The Overlapping Risk Profile Between Dialysis Patients Listed and Not Listed for Renal Transplantation

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection

Value of Posttransplant Antibody Tests in the Evaluation of Patients with Renal Graft Dysfunction

Improving Long‐Term Outcomes for Transplant Patients: Making the Case for Long‐Term Disease‐Specific and Multidisciplinary Research

Elevated Incidence of Posttransplant Erythrocytosis After Simultaneous Pancreas Kidney Transplantation

A ‘Weight‐Listing’ Paradox for Candidates of Renal Transplantation?

The Noninferiority Trial: Don't Don't Do It

Suchergebnisse filtern